Tenaya Therapeutics (TNYA) Amortizatization of Intangibles (2021 - 2026)
Tenaya Therapeutics (TNYA) recorded quarterly Amortizatization of Intangibles of $654000.0 in Q1 2026, up 145.99% quarter-over-quarter from -$1.4 million in Q4 2025, and up 9.73% on a YoY basis from $596000.0 in Q1 2025.
Tenaya Therapeutics (TNYA) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $654000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 9.73% year-over-year to $654000.0; the TTM figure through Mar 2026 stood at $469000.0 (down 3.5% YoY), while the FY2025 annual figure was $411000.0, up 323.37% from the prior year.
- Amortizatization of Intangibles was $654000.0 for Q1 2026 at Tenaya Therapeutics, up from -$1.4 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.1 million in Q2 2023 to a low of -$2.8 million in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $218000.0 across 5 years, with a median of $612000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles tumbled 496.5% in 2023, then soared 905.41% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$383000.0 in 2022, then jumped by 310.44% to $806000.0 in 2023, then plunged by 452.23% to -$2.8 million in 2024, then soared by 49.91% to -$1.4 million in 2025, then surged by 145.99% to $654000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $654000.0 (Q1 2026), -$1.4 million (Q4 2025), and $625000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Tenaya Therapeutics | 148.89 Mn | 148.89 Mn | - | 654,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 654,000.00 |
| Mar 31, 2026 | 654,000.00 |
| Dec 31, 2025 | -1.42 Mn |
| Dec 31, 2025 | -1.42 Mn |
| Sep 30, 2025 | 625,000.00 |
| Sep 30, 2025 | 625,000.00 |
| Jun 30, 2025 | 612,000.00 |
| Jun 30, 2025 | 612,000.00 |
| Mar 31, 2025 | 596,000.00 |
| Mar 31, 2025 | 596,000.00 |
| Dec 31, 2024 | -2.84 Mn |
| Dec 31, 2024 | -2.84 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | -74,000.00 |
| Mar 31, 2024 | -74,000.00 |
| Dec 31, 2023 | 806,000.00 |
| Dec 31, 2023 | 806,000.00 |